# HRQoL During PRRT in Patients With NETs

> **NCT05427032** · — · COMPLETED · sponsor: **Uppsala University** · enrollment: 756 (actual)

## Conditions studied

- Neuroendocrine Tumors
- Quality of Life
- Peptide Receptor Radionuclide Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05427032
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-10
- **Primary completion:** 2018-05-15
- **Final completion:** 2018-12-10
- **Target enrollment:** 756 (ACTUAL)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427032, "HRQoL During PRRT in Patients With NETs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05427032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*